Wealthier Patients Living Longer Than Poorer Patients With Glioblastoma
6/03/2011

Survival rates of wealthier patients and those younger than 70 with glioblastoma, the most common and aggressive malignant brain tumor, have improved since 2000, whereas rates for those living in poorer areas and older than 70 have remained stagnant, according to an abstract being presented at the American Society of Clinical Oncology annual meeting in Chicago by Thomas Jeffers...

Physicians Discover How Cancer Drug Works To Help Prevent Recurrent Kidney Disease
6/03/2011

A collaboration of Miller School physicians, surgeons and scientists has unlocked the mechanism of a drug used to prevent recurrent kidney disease. The finding, which has implications for the diagnosis and treatment of many other diseases, involves the action of rituximab, a B-cell lymphoma therapy, in treating recurrent focal segmental glomerulosclerosis (FSGS) in children and young adults...

Emerging Trends In Radiation Therapy For Women Over 70 With Early Stage Breast Cancer
6/03/2011

Patterns of radiation usage in breast conserving therapy for women 70 years and older with stage I breast cancer are changing: more women are opting for radioactive implants and those with estrogen positive tumors are opting out of radiation therapy, according to an abstract being presented at the American Society of Clinical Oncology annual meeting in Chicago by Thomas Jeffers...

Stopping Heart Disease In Cancer Patients Before It Starts
6/03/2011

Researchers in the Faculty of Medicine & Dentistry are trying to reverse a devastating trend: cancer survivors developing cardiovascular disease, one of the top two killers in Canada...

Personalised First-Line Therapy Stalls Lung Cancer For Nearly Twice As Long As Chemotherapy
6/03/2011

Roche today announced results from the first Phase III study with erlotinib (Tarceva®) in Western patients with a genetically mutated type of advanced non-small cell lung cancer (NSCLC)...

One Step Closer To A Stem Cell Treatment To Prevent Leukemia Returning
6/03/2011

Researchers at King's College London have identified a way of eliminating leukaemic stem cells, which could lead to new treatments that may enable complete remission for leukaemia patients. An early study in mice has shown that leukaemic stem cells can be abolished by suppressing two proteins found in the body...

Survival In Refractory Lung Cancer Patients Extended By Drug Combination
6/03/2011

Scientists have identified a drug combination, when used in advanced lung cancer patients, shows a survival advantage in patients who no longer respond to existing therapies. They found that bexarotene and erlotinib can each repress the critical cell cycle regulator: cyclin D1...

FDA: Treatment With Angiotensin Receptor Blockers For High Blood Pressure Does Not Increase Risk Of Cancer
6/03/2011

The U.S. Food and Drug Administration today announced that a group of medications used to control high blood pressure, called angiotensin receptor blockers (ARBs), do not increase the risk of developing cancer in patients using the medications...

Silencing Deadly Cellular Cross Talk In Breast Cancer
6/03/2011

While it is already known that breast cancer cells create the conditions for their own survival by communicating their needs to the healthy cells that surround them, Australian researchers have identified a new way of turning off that cellular cross talk...

FDA: Breast Thermography Not A Substitute For Mammography
6/03/2011

The U.S. Food and Drug Administration today warned women not to substitute breast thermography for mammography to screen for breast cancer. Unlike mammography, in which an X-ray of the breast is taken, thermography produces an infrared image that shows the patterns of heat and blood flow on or near the surface of the body...